Literature DB >> 1809604

Doppler velocimetry studies of the uterine artery in the early prediction of pre-eclampsia and intra-uterine growth retardation.

K F Harrington1, S Campbell, S Bewley, S Bower.   

Abstract

Pre-eclampsia/proteinuric pregnancy-induced hypertension (PPIH) and intra-uterine growth retardation (IUGR) are associated with incomplete trophoblastic invasion of the uterus in the first half of pregnancy. The uteroplacental circulation can be observed using Doppler ultrasound. We have performed two mid pregnancy screening studies of our antenatal population in the last three years, to assess the use of Doppler velocimetry studies at that time in predicting the subsequent development of PPIH and IUGR. In the first study continuous wave Doppler ultrasound was used to study the uterine circulation. The Resistance Index (RI) was measured once in both uterine arteries in 925 patients between 16 and 24 weeks gestation. There was a significant association between an abnormal RI (greater than 95th centile) and the subsequent development of PPIH, IUGR and severe complications of pregnancy. However, even though the specificity (95%) was high the sensitivity was low (25%). There was no significant association with nonproteinuric hypertension. In an attempt to improve the sensitivity for the second study, colour flow imaging and the use of a diastolic notch as well as an elevated RI were introduced. 2437 patients had continuous-wave Doppler studies of the uterine circulation performed at 20 weeks gestation. 16% had abnormal waveforms, persisting in 5.4% at 24 weeks and 4.6% at 26 weeks when measured with colour/pulsed Doppler. The high sensitivity (76%) of this innovation at 20 weeks is retained at 24 and 26 weeks, while the specificity (from 86% to 97%) and positive predictive value (13% to 44%) improve progressively with gestation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1809604

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  22 in total

1.  Unexplained fetal death: another anti-angiogenic state.

Authors:  Jimmy Espinoza; Tinnakorn Chaiworapongsa; Roberto Romero; Yeon Mee Kim; Gi Jin Kim; Jyh Kae Nien; Juan Pedro Kusanovic; Offer Erez; Emmanuel Bujold; Luis F Gonçalves; Ricardo Gomez; Samuel Edwin
Journal:  J Matern Fetal Neonatal Med       Date:  2007-07

2.  Predictive accuracy of the first trimester Doppler scan: a meta-study.

Authors:  Naira Roland Matevosyan
Journal:  Wien Med Wochenschr       Date:  2015-06-16

3.  Preeclampsia before 20 weeks of gestation: a case report and review of the literature.

Authors:  Mari Tanaka; Yasushi Tsujimoto; Kimihiko Goto; Kana Kumahara; Saeko Onishi; Sachio Iwanari; Daiki Fumihara; Syo Miki; Masaki Ikeda; Kanae Sato; Hiroshi Sato; Masaya Hirose; Hiroya Takeoka
Journal:  CEN Case Rep       Date:  2014-08-09

4.  Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age.

Authors:  Digna R Velez Edwards; Roberto Romero; Juan Pedro Kusanovic; Sonia S Hassan; Shali Mazaki-Tovi; Edi Vaisbuch; Chong Jai Kim; Offer Erez; Tinnakorn Chaiworapongsa; Brad D Pearce; Jacquelaine Bartlett; Lara A Friel; Benjamin A Salisbury; Madan Kumar Anant; Gerald F Vovis; Min Seob Lee; Ricardo Gomez; Ernesto Behnke; Enrique Oyarzun; Gerard Tromp; Ramkumar Menon; Scott M Williams
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07-09

5.  Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension?

Authors:  Jimmy Espinoza; Juan Pedro Kusanovic; Ray Bahado-Singh; Maria Teresa Gervasi; Roberto Romero; Wesley Lee; Edi Vaisbuch; Shali Mazaki-Tovi; Pooja Mittal; Francesca Gotsch; Offer Erez; Ricardo Gomez; Lami Yeo; Sonia S Hassan
Journal:  J Ultrasound Med       Date:  2010-07       Impact factor: 2.153

6.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

7.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

8.  Severe preeclampsia is characterized by increased placental expression of galectin-1.

Authors:  Nandor Gabor Than; Offer Erez; Derek E Wildman; Adi L Tarca; Samuel S Edwin; Asad Abbas; John Hotra; Juan Pedro Kusanovic; Francesca Gotsch; Sonia S Hassan; Jimmy Espinoza; Zoltan Papp; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-07

9.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

10.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.